Cancer C18 C20 C50 C51 C52 C55 C56 C61 C90 C91 C92 C93 C94 C95
Conditions
Interventions
Group 1: Survey of 300 cancer patients with a questionnaire over a period of 4 months
establishment of a tumor board integrative oncology. After 6 months duration survey of 300 cancer patients using a questionnaire.
Sponsors
Tumorzentrum Freiburg CCCF
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: In the cross-sectional study all patients are included who have a tumor as a secure main diagnostic and have been in an organ center (breast center, gynecologic oncology, intestine center, prostate center, or leukemia center) at the University Hospital of Freiburg, and had 8 weeks before a treatment decision or were previously presented in a tumor board. To get sufficient homogeneity after stratification into the groups , only patients are interviewed who have received the following diagnoses: colorectal cancer, prostate cancer, breast cancer, gynecological tumors or leukemia. In these highly prevalent tumor entities is a long-term therapy possible because they have a longer survival time. This ensures that the patients could benefit from the introduction of integrative oncology tumor boards. In the longitudinal study cancer patients are included who will be presented in the integrative oncology tumor board because they would like to have a complementary medical treatment decision or need a second opinion or need a recommendation as the therapeutic treatment must be changed. This can be oncology patients from the outpatient clinic for naturopathy or oncology patients from the outpatient departments or other cancer patients from the wards of University Hospital in Freiburg.
Exclusion criteria
Exclusion criteria: Excluded are patients who are not powerful in the use of the German language or for other reasons are unable to complete the questionnaires. All patients who are younger than 18 years. Lack of consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The first main objective of the study is to measure the effect of the establishment of an integrative oncology tumor board on the patients' satisfaction concerning the: a) medical care provided by the University Hospital Freiburg (UKF) b) complementary medical care at the UKF c) involvement in decision making The second main objective is measure the influence of the establishment of an integrative oncology tumor board on the general information of patients about complementary medicine and the use of complementary medicine. All measurement are done with questionnaires. First endpoint is after 5 months, the second after 16 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Of further interest are a.) the typical sources of information for complementary medicine b.) its impact on communication with patients about the existing tumor boards c.) change of use of complementary medicine In the long term, a comparison is being considered in survival time, which can be done in a Follow up study. Regardless of the introduction of integrative oncology tumor board the influence of various factors like the patient's gender, age, their education, the tumor entity and stage of the tumor on the use of complementary medicine will be examined. | — |
Countries
Germany
Contacts
Public ContactMartina Bischoff
Tumorzentrum Ludwig Heilmeyer CCCF
Outcome results
None listed